Hovione to Buy Irish Pharma Ingredients Site from Pfizer

Hovione (Loures, Portugal) says it has agreed to buy Pfizer’s multipurpose active pharmaceutical ingredient (API) plant at Loughbeg, Ireland. The deal is scheduled to be completed by early April 2009. Financial terms were not disclosed. Loughbeg: Hovione eyes first site in Ireland. The site, to be renamed Hovione Cork, manufactures intermediates for APIs for Pfizer’s cholesterol-lowering drug Lipitor. Hovione, which has plants in Portugal and China, says it will continue to provide manufacturing services for Pfizer under the deal. Hovione Cork will...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers